Senate Bill 5981, signed into law by Gov. Bob Ferguson on March 25, strengthened the federal 340B Drug Pricing Program, ...
A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
Filing in 10th Circuit Highlights Need for Oversight of Runaway PBM and Contract Pharmacy Profiteering WASHINGTON, DC, ...
LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...
A federal judge has, at least temporarily, nixed a longstanding restriction on whether some 340B hospitals could use group ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...
Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.
Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...
"The savings from this program support pharmacy services, emergency care, behavioral health, and care for patients who are ...
Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...
Drug companies are more likely than hospitals to violate 340B regulations, according to a recent American Hospital Association report. The 340B Drug Pricing Program has been under constant attack on ...
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results